These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22316435)

  • 1. Review article: the extra-skeletal effects of vitamin D in chronic hepatitis C infection.
    Cholongitas E; Theocharidou E; Goulis J; Tsochatzis E; Akriviadis E; Burroughs K
    Aliment Pharmacol Ther; 2012 Mar; 35(6):634-46. PubMed ID: 22316435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: the treatment of hepatitis C virus recurrence after liver transplantation.
    Arjal RR; Burton JR; Villamil F; Rosen HR
    Aliment Pharmacol Ther; 2007 Jul; 26(2):127-40. PubMed ID: 17593060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D controls T cell activation: implication for causal association between vitamin D deficiency and fibrosis in chronic hepatitis C.
    Shen L
    Hepatology; 2010 Nov; 52(5):1864. PubMed ID: 20672383
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis.
    García-Álvarez M; Pineda-Tenor D; Jiménez-Sousa MA; Fernández-Rodríguez A; Guzmán-Fulgencio M; Resino S
    Hepatology; 2014 Nov; 60(5):1541-50. PubMed ID: 24975775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-livering the message: the importance of vitamin D status in chronic liver disease.
    Kitson MT; Roberts SK
    J Hepatol; 2012 Oct; 57(4):897-909. PubMed ID: 22634121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
    Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D
    Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of steatosis on progression of fibrosis and virological response in chronic hepatitis C cases.
    Rafi H; Kabbaj N; Salihoun M; Amrani L; Acharki M; Guedira M; Nya M; Amrani N
    Arab J Gastroenterol; 2011 Sep; 12(3):136-8. PubMed ID: 22055591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis C and liver transplantation].
    Durand F
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B82-90. PubMed ID: 12180312
    [No Abstract]   [Full Text] [Related]  

  • 10. Vitamin D for your patients with chronic hepatitis C?
    Rahman AH; Branch AD
    J Hepatol; 2013 Jan; 58(1):184-9. PubMed ID: 22871501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D deficiency in hepatitis C virus infection: what is old? what is new?
    Jin CN; Chen JD; Sheng JF
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):741-746. PubMed ID: 29664746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E; Bergk A; Berg T
    Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insight of vitamin D in chronic liver diseases.
    Chen EQ; Shi Y; Tang H
    Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):580-5. PubMed ID: 25475859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.
    Loguercio C; Federico A; Masarone M; Torella R; Blanco Cdel V; Persico M
    Am J Gastroenterol; 2008 Dec; 103(12):3159-66. PubMed ID: 18786125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined antiviral treatment in a patient with recurrent chronic hepatitis C after liver transplantation].
    Csák T; Folhoffer A; Horváth A; Lengyel G; Kóbori L; Szalay F
    Orv Hetil; 2004 Sep; 145(39):2003-6. PubMed ID: 15553912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of pegylated interferon beta-1a therapy on the liver fibrosis in chronic hepatitis C: a semi-quantitative analysis].
    Rao HY; Li J; Zhang LF; Chen HY; Zhu LM; Wei L; Sun Y; Wang H
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):96-100. PubMed ID: 18353212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of chronic hepatitis C.
    Asselah T; Boyer N; Ripault MP; Martinot M; Marcellin P
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):9-23. PubMed ID: 17415342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial.
    Everson GT; Shiffman ML; Morgan TR; Hoefs JC; Sterling RK; Wagner DA; Kulig CC; Curto TM; Wright EC;
    Aliment Pharmacol Ther; 2008 May; 27(9):798-809. PubMed ID: 18266997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hyperparathyroidism - is vitamin D supplementation safe?
    Rankin W
    Aust Fam Physician; 2011 Nov; 40(11):881-4. PubMed ID: 22059217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.